GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
8W4N | 8W4N | Crystal structure of EndoSz mutant D234M, in space group P21, in complex with oligosaccharide G2S1 | |
8W4M | P0DOX5 | Crystal structure of open conformation of human immunoglobulin Fc in presence of EndoSz | |
8W4L | P0DOX5 | Crystal structure of closed conformation of human immunoglobulin Fc in presence of EndoSz | |
8W0Y | 8W0Y | Crystal structure of broadly neutralizing antibody hcab17 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
8W0Y | A0A2P0NE15 | Crystal structure of broadly neutralizing antibody hcab17 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
8W0X | A0A2P0NE15 | Crystal structure of broadly neutralizing antibody hcab40 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
8W0X | 8W0X | Crystal structure of broadly neutralizing antibody hcab40 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
8W0W | A0A2P0NE15 | Crystal structure of broadly neutralizing antibody hcab64 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
8W0W | 8W0W | Crystal structure of broadly neutralizing antibody hcab64 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
8W0V | A0A2P0NE15 | Crystal structure of broadly neutralizing antibody hcab55 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
8W0V | 8W0V | Crystal structure of broadly neutralizing antibody hcab55 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
8VZ7 | P11712 | Crystal Structure of Human Cytochrome P450 2C9*27 (R150L) Genetic Variant in Complex with the Drug Losartan | |
8VYG | 8VYG | SARS-CoV-2 S RBD (C.37 Lambda variant) plus S309 Fab, local refinement | |
8VYG | P0DTC2 | SARS-CoV-2 S RBD (C.37 Lambda variant) plus S309 Fab, local refinement | |
8VYF | P0DTC2 | SARS-CoV-2 S NTD (C.37 Lambda variant) plus S2L20 and S2X303 Fabs, local refinement | |
8VYF | 8VYF | SARS-CoV-2 S NTD (C.37 Lambda variant) plus S2L20 and S2X303 Fabs, local refinement | |
8VYE | 8VYE | SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs | |
8VYE | P0DTC2 | SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs | |
8VWP | 8VWP | Langya Virus attachment (G) glycoprotein with K85L/L86K mutation | |
8VVL | Q8JSZ3 | CCHFV GP38 bound to c13G8 Fab | |
8VVL | 8VVL | CCHFV GP38 bound to c13G8 Fab | |
8VVK | Q8JSZ3 | CCHFV GP38 bound to ADI-46143 Fab | |
8VVK | 8VVK | CCHFV GP38 bound to ADI-46143 Fab | |
8VV3 | B3GTD7 | Structure of the insect gustatory receptor Gr9 from Bombyx mori in complex with L-sorbose | |
8VUI | 8VUI | Structure of FabS1CE-EPR-1, an elbow-locked Fab, in complex with the erythropoeitin receptor | |
8VUI | P19235 | Structure of FabS1CE-EPR-1, an elbow-locked Fab, in complex with the erythropoeitin receptor | |
8VUE | A0A0E3TW62 | L5A7 Fab bound to Indonesia2005 Hemagglutinin | |
8VUE | A7Y8E2 | L5A7 Fab bound to Indonesia2005 Hemagglutinin | |
8VUE | 8VUE | L5A7 Fab bound to Indonesia2005 Hemagglutinin | |
8VT3 | Q6WB98 | cryo-EM structure of HMPV (MPV-2cREKR) | |
8VT2 | 8VT2 | cryo-EM structure of HMPV (MPV-2c) | |
8VSP | P01909 | Cryo-EM structure of human invariant chain in complex with HLA-DQ | |
8VSP | P01920 | Cryo-EM structure of human invariant chain in complex with HLA-DQ | |
8VSP | P04233 | Cryo-EM structure of human invariant chain in complex with HLA-DQ | |
8VRV | A0A168DBN0 | GII.4c H2-tri HBGA norovirus protruding domain | |
8VRN | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus PPTQ | |
8VRN | 8VRN | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus PPTQ | |
8VRN | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus PPTQ | |
8VRN | 8VRN | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus PPTQ | |
8VRN | P14867 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus PPTQ | |
8VRN | P14867 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus PPTQ | |
8VRN | P18507 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus PPTQ | |
8VRN | P18507 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus PPTQ | |
8VQY | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus methaqualone | |
8VQY | 8VQY | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus methaqualone | |
8VQY | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus methaqualone | |
8VQY | 8VQY | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus methaqualone | |
8VQY | P14867 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus methaqualone | |
8VQY | P14867 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus methaqualone | |
8VQY | P18507 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus methaqualone |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024